⌘K

Login Start Free

Home/Filings/4/0000950170-24-069464

4//SEC Filing

GANNON STEVEN 4

Accession 0000950170-24-069464

CIK 0001582313other

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:42 PM ET

Size

5.2 KB

Accession

0000950170-24-069464

Insider Transaction Report

Form 4

Period: 2024-06-05

Xenon Pharmaceuticals Inc.XENE

Director

Transactions

Award
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 total
Exercise: $38.16Exp: 2034-06-04→ Common Shares (15,542 underlying)

Footnotes (1)

[F1]Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1

filerCIK 0001643085

Filing Metadata

Form type: 4
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 5:42 PM ET
Size: 5.2 KB

View on SEC.gov